Swine Fever Vaccine Market, by Type, by Vaccine Type (Live-Attenuated, Chimeric, Subunit or vector system based, and Replicon vaccine), by Distribution Channel, and by Region Size, Share, Outlook, and Opportunity Analysis, 2024

Description

The global swine fever vaccine market is estimated to be valued at USD 3,028.7 Mn in 2024 and is expected to exhibit a CAGR of 5.9% during the forecast period (2024-2031).

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 3,028.7 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	5.90%	2030/2031 Value Projection:	US$ 4,536.4 Mn

Global Swine Fever Vaccine Market Value (USD MN), by Region, 2024

There are two types of swine fever - Classical Swine Fever (CSF) and African Swine Fever (ASF). Classical swine fever (CSF) is an extremely contagious viral disease in pigs. The severity of the disease varies with the strain of the virus, the immune status of the herd, and the age of the pig. African swine fever, on the other hand, is a highly contagious and deadly viral disease affecting both domestic and feral swine of all ages. Acute forms of both ASF and CSF can cause high death rates, with mortality approaching 100% in the most severe form of ASF. Both diseases may also occur in milder forms with lower mortality rates. Swine fever could be considered a possibility in case of a sudden increase in deaths in a group of pigs. Clinical signs of acute forms of both ASF and CSF include depression, fever, loss of appetite, and red, purple, or blue blotching of the ears, nose, and limbs. Vomiting and diarrhea (bloody diarrhea for ASF) may occur as the disease progresses, along with breathing difficulties and coughing. The diseases spread through direct contact with infected pigs or contact with contaminated pens, trucks, or clothing. In both diseases, pigs can remain carriers of the disease for long period and therefore moving pigs during an outbreak must be restricted.

Market Dynamics

Increasing efforts by the government bodies to create awareness and prevent the spread of swine fever by organizing awareness campaigns are expected to drive the market growth over the forecast period. For instance, in June 2022, the United States Department of Agriculture's (USDA) Animal and Plant Health Inspection Service (APHIS) announced new efforts to help prevent the introduction and spread of African swine fever in the U.S. Through an outreach and awareness campaign called "Protect Our Pigs," APHIS will support commercial pork producers, veterinarians, and pig owners with information and resources to help safeguard America's swine population and the pork industry.

Key features of the study:

This report provides an in-depth analysis of the global swine fever vaccine market, market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global swine fever vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck & Co., Inc. (Merck Animal Health), Ceva, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Indian Immunologicals Ltd., Bioveta, a.s., Komipharm, and EC21 Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global swine fever vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global swine fever vaccine market

Detailed Segmentation:

Global Swine Fever Vaccine Market, By Type:
- African Swine Fever
- Classical Swine Fever
Global Swine Fever Vaccine Market, By Vaccine Type:
- Live-Attenuated
- Chimeric (Live-attenuated or inactivated)
- Subunit or vector system based
- Replicon vaccine
Global Swine Fever Vaccine Market, By Distribution Channel:
- Public
- Private
Global Swine Fever Vaccine Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Merck & Co., Inc. (Merck Animal Health)
- Ceva
- Zoetis Services LLC
- Boehringer Ingelheim International GmbH
- Indian Immunologicals Ltd.
- Bioveta, a.s.
- Komipharm
- EC21 Inc.

Product Code: CMI5195

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Epidemiology
Regulatory Scenario
PEST Analysis
New Product Approval/Launch

4. Global Swine Fever Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

Economic Impact
COVID-19 Epidemiology
Demand and Supply Analysis

5. Global Swine Fever Vaccine Market, By Type, 2019 - 2031, (US$ Million)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
African Swine Fever
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Million)
Classical Swine Fever
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Million)

6. Global Swine Fever Vaccine Market, By Vaccine Type, 2019 - 2031, (US$ Million)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Live-Attenuated
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Million)
Chimeric (Live-attenuated or inactivated)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Million)
Subunit or vector system based
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Million)
Replicon vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Million)

7. Global Swine Fever Vaccine Market, By Distribution Channel, 2019 - 2031, (US$ Million)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Public
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Million)
Private
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Million)

8. Global Swine Fever Vaccine Market, By Region, 2019 - 2031, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, By Region, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (US$ Million)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Merck & Co., Inc. (Merck Animal Health)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ceva
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zoetis Services LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Indian Immunologicals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bioveta, a.s.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Komipharm
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
EC21 Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. Section

References
Research Methodology
About Us and Sales Contact

Swine Fever Vaccine Market, by Type, by Vaccine Type (Live-Attenuated, Chimeric, Subunit or vector system based, and Replicon vaccine), by Distribution Channel, and by Region Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031